# AbbVie Inc. (ABBV) — Q1-2013 Earnings Results

**Report date:** 2013-04-26 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2013

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Up 3.62%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.68 | N/A | +3.34% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on their core products. They emphasized the importance of their pipeline for future growth.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They expressed confidence in ongoing product development.

> Focus remains on pipeline advancements and market expansion.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

AbbVie's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock rose by 3.62% following the announcement, reflecting investor confidence in the company's performance and future prospects. However, the lack of revenue data and guidance leaves some uncertainty about the overall financial health moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2013_